{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.98",
    "chg": -0.23,
    "chgp": "-1.62%",
    "dir": -1,
    "prev_price": "14.21",
    "mcapval": "1,314.12 Cr",
    "mcap": "Small Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "14.25 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-4000699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SyncomFormulati_mojoScore_4000699.png",
        "date": "2026-05-20 10:10:56",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3982736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SyncomFormulati_mojoScore_3982736.png",
        "date": "2026-05-09 10:10:36",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3966328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyncomFormulati_mojoScore_3966328.png",
        "date": "2026-04-28 10:10:55",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3950634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyncomFormulati_mojoScore_3950634.png",
        "date": "2026-04-17 10:10:58",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3934185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyncomFormulati_mojoScore_3934185.png",
        "date": "2026-04-06 10:10:28",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3917838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_mojoScore_3917838.png",
        "date": "2026-03-26 10:10:26",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 15,
    "sid": "831770",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-May-2026",
      "details": "Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026.",
      "datetime": "22-May-2026",
      "details": "Pursuant to regulation 33(3)(d) of SEBI LODR Regulations 2015 we are pleased to submit the financials for the year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026",
      "datetime": "22-May-2026",
      "details": "Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations 2015 we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors Report thereon by Statutory Auditors Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March 2026 in PDF Format which were approved by the Audit Committee and Board of Directors at their meeting held on Friday 22nd May 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Syncom Formulations (India) Ltd is Rated Sell

2026-05-20 10:10:56

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read More

Syncom Formulations (India) Ltd is Rated Sell

2026-05-09 10:10:36

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read More

Syncom Formulations (India) Ltd is Rated Sell

2026-04-28 10:10:55

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read More

Syncom Formulations (India) Ltd is Rated Sell

2026-04-17 10:10:58

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read More

Syncom Formulations (India) Ltd is Rated Sell

2026-04-06 10:10:28

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read More

Syncom Formulations (India) Ltd is Rated Sell

2026-03-26 10:10:26

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read More

View All News